Jo Bhakdi is the founder and CEO of Quantgene. His work in machine learning, sequencing technology, and DNA extraction procedures defines the cutting edge of genomic diagnostics, early disease detection, and precision medicine.
‍
Prior to Quantgene, Jo founded i2X, an investment framework that composes low-risk Venture Capital portfolios across large numbers of technology startups. The i2X platform laid important foundations for advanced analytics in both financial and biotechnology applications, such as the Quantgene machine learning platform.
‍
Bhakdi holds a Masters in Economics and Psychology from Tubingen University, one of Germany’s leading academic institutions, with a focus on financial theory and statistics. He kicked off his career at WPP and Omnicom, where he held Strategy and Executive Director positions.
‍
Beyond his focus on technology and the future of medicine, Bhakdi is dedicated to bringing together the best and brightest and transforming them into pioneers, pushing the boundaries of health, life, and innovation for all.

Monika E. Hagen, MD, MBA is the Chief Medical Officer of Quantgene and a board certified General Surgeon, specializing in bariatric surgery. Trained in Germany, Switzerland, and the United States, she has over a decade of experience as a medical doctor, academic surgeon, teacher, medical device expert, and clinical trial specialist. She also received her MBA from the University of Wales in Cardiff, UK.

Dr. Hagen is an international thought leader and lecturer in bariatric and minimally invasive surgery, as well as surgical robotic technology and its clinical applications. She is a frequent speaker at medical conferences and has published extensively on topics ranging from robotic surgery, to clinical trial design to the future of medicine.

Prior to joining Quantgene and utilizing her clinical, strategic planning, and business development expertise, she has served as a regular consultant to financial, technology, medical, and biotech companies. Dr. Hagen divides her time between professional roles in Geneva, Switzerland, Silicon Valley, and Santa Monica, California.

William Ricketts, PhD is the Director of Clinical Affairs at Quantgene and is responsible for developing studies to validate new products and identifying areas of unmet medical need.

Dr. Ricketts has been in diagnostic development for more than fifteen years. He has designed, developed, and launched several CLIA cleared tests for cancer and autoimmune disease. In this role, he has written protocols and worked extensively with physicians to validate new tests and technologies for use in the clinical laboratory.

Dr. Ricketts received his BA from the University of Virginia and his PhD from the University of CA-San Diego. He is currently a Society of Gynecologic Oncology member and the American Association of Cancer Researchers.

Troy Skabelund is the Interim CFO at Quantgene where he is responsible for overseeing the financial planning and growth of the company. Troy has over 20 year of experience as a CFO and financial expert for organizations of all sizes and industries, including 12 years at the Walt Disney Company.

Troy is well respected in the financial industry, with a proven track record for raising capital and driving acquisitions and exits. He started his career as a systems consultant for PWC in Seattle Washington and was a graduate of Brigham Young University (BS, MAcc).

Troy is also a CPA, CGMA, CISA, and former chapter president for the Institute of Internal Auditors.

Jennifer is responsible for Quantgene’s marketing strategy, planning and implementation across corporate, employer and product brands. She manages the marketing team and is working to build out the department structure as the company continues to grow.

Jennifer brings with her 14 years of healthcare marketing and advertising experience. She has deep expertise in strategic patient-centric marketing having worked with world-leading companies including Gilead, J&J, Merck, Sanofi and Lilly. She has also led the launch of several pharmaceutical brands including Cialis for BPH, Sanofi’s insulin Toujeo and the omni-channel support platform for Gilead’s Hepatitis C portfolio. Most recently, Jennifer held the role of Group Account Director at Wunderman Health overseeing multiple pieces of business with a focus on data-driven marketing.

Jennifer spent 9 years growing up in Tokyo Japan; an experience that has added to her understanding of diversity and nuance in her work. Jennifer has a B.A. in Psychology from Columbia University’s Barnard College.

Robert is responsible for Quantgene's software infrastructure and architecture to integrate clinical, laboratory and machine learning.

Robert brings 17 years experience from the e-commerce sector, having worked with large global brands such as Columbia Sportswear, Tory Burch, Alexander Wang, S.Oliver and many more to connect their complex system landscapes into one coherent and efficiently working whole. Most recently, he worked at Mobizcorp Europe, a leading Salesforce Commerce Cloud partner, as Director of Engineering. Robert led a technical evolution to establish 24/7 Support, Security and Performance Audit services. He also helped to lead the development of mentorship and training programs within the company.

Robert has an M.Sc. in Software Engineering from Freie University of Berlin.